Illumina on Tuesday unveiled what it calls the world’s largest functional cell dictionary that, when paired with artificial intelligence, will help accelerate drug discovery. Dubbed the Billion Cell ...
Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.
Morning Overview on MSN
New AI model could radically change genetic testing and drug discovery
A new generation of artificial intelligence is starting to read the human genome with a fluency that would have sounded like ...
News Medical on MSN
New atlas of brain lysosomes sheds light on neurodegenerative disorders
Functioning brain cells need a functioning system for picking up the trash and sorting the recycling. But when the cellular ...
Knowing which lysosomal proteins are enriched in which brain cell types will help better understand contribution to neurological disorders.
SAN DIEGO, Jan. 13, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today introduced the world's largest genome-wide genetic perturbation dataset, being built to accelerate drug discovery through ...
Using single-cell epigenomic profiling of immune cells from 110 individuals, researchers show that genetic variation and ...
Scientists have mapped the sensory neurons in bone for the first time, and identified their dual role in reporting and ...
AI across the pharmaceutical ecosystem. The Illumina Billion Cell Atlas is the first tranche of its program to build a 5 billion cell atlas over three years, and will be the most comprehensive map of ...
The Atlas will enable the validation of genetic targets and training of AI models at unprecedented scale SAN DIEGO, Jan. 13, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today introduced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results